Dr Christopher Chen is a Senior Clinician-Scientist at the Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and Director of the Memory Aging and Cognition Centre.
His early medical and research training was at the Universities of Cambridge and Oxford as well as the Institute of Neurology, London.
Since returning to Singapore, Dr Chen has developed multi-disciplinary research programmes with extensive international collaborations. His major research and clinical interests are in neuroimaging, molecular biology and treatment of stroke and dementia. He has published over 425 peer reviewed papers, is the Principal Investigator for several studies on the treatment as well as prevention of stroke and dementia, including SINGER which is a multiple lifestyle interventional trial for older adults at risk of dementia. He serves on journal editorial boards and has been a member of trial steering committees and advisory panels.
Currently he is President of the Asian Society Against Dementia, Secretary-Treasurer of the Asian & Oceanian Association of Neurology and past-chair of the International Society for Vascular Behavioural and Cognitive Disorders. He is also Co-chair of the World Stroke Organisation Future Leaders Programme.